177lu-psma-617
novartis
['pluvicto', 'prostate', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)']
concern exists with giving 2 radionuclide therapies within a short period of time, but research from #gu23 said that administering pluvicto within 6 months of radium-223 treatment was safe and efficacious in #prostatecancer treatment. 
Cancer updates, research and education for patients with cancer, survivors and their caregivers to become empowered advocates in their journey.